Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma
about
Discovery of new biomarkers for malignant mesotheliomaSerum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisThe development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapyBioanalytical techniques for detecting biomarkers of response to human asbestos exposureMesothelioma - Update on Diagnostic StrategiesAsbestos-induced lung diseases: an updateGuidelines for the diagnosis and treatment of malignant pleural mesotheliomaHyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesotheliomaMarkers for the non-invasive diagnosis of mesothelioma: a systematic reviewCD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.What's the place of immunotherapy in malignant mesothelioma treatments?Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis.LRRN4 and UPK3B are markers of primary mesothelial cellsAuto-antibodies to β-F1-ATPase and vimentin in malignant mesotheliomaMalignant pleural mesothelioma: an update on diagnosis and treatment options.Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaBacterial infection elicits heat shock protein 72 release from pleural mesothelial cells.Identification of novel markers for the diagnosis of malignant pleural mesothelioma.Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum.Biomarkers for early detection of malignant mesothelioma: diagnostic and therapeutic application.Biomarkers for malignant pleural mesothelioma: current status.Road ahead to respiratory health: experts chart future research directions.Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational studyDiagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesotheliomaAdvances in the investigation and treatment of pleural effusions.Soluble markers for diagnosis of malignant pleural mesothelioma.Diagnostic molecular biomarkers for malignant pleural effusions.Asbestos-related pleuropulmonary diseases: benign and malignant.Malignant pleural mesothelioma: from the bench to the bedside.Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.Mesothelial cells activate the plasma kallikrein-kinin system during pleural inflammation.Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.Dietary vitamin D supplementation does not reduce the incidence or severity of asbestos-induced mesothelioma in a mouse model.A predictive equation to adjust for clinical variables in soluble mesothelin-related protein (SMRP) levels.Asbestos and the lung in the 21st century: an update.Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial).
P2860
Q26849620-399D82C0-CDFC-4D9A-B6F7-94C76D03D7C2Q26860736-33FE2115-6C4F-4BBF-8542-3B38B32679C5Q27314606-DB3AA11D-1172-4C7A-8F76-96D2773235E3Q28082088-0229B914-0C75-425C-A0DE-0DB3FCA1C80DQ28392693-2D44F03E-18CF-4F5E-9A0D-1A15EBF6BC4EQ28393032-5564A827-70A0-4B73-80CA-DD4C6346C097Q28394028-4B9311F4-61BA-4B54-9BD4-0363F6565E0EQ28535472-67314EB0-DA37-411D-8047-9E4F7933DDF7Q30499716-69BAAFB1-0B97-43FC-8BB1-07872A44B969Q33556551-C6941153-7724-4422-9CD3-B803BEDD58A9Q33781142-91234C24-8955-40B4-9C20-18182DC02EECQ33815929-42F1ACEA-C374-4724-ADF2-7301E207B02EQ34044878-E18F77A1-3EEF-4A1E-828E-B3D2CF86E153Q34056345-278537AF-4594-4496-BA02-59E159BE94DBQ34513958-2C2C94F0-F14F-494E-9CC7-E6CC39BD0375Q34614847-44281220-7BA2-4DA3-888B-EF71C7413FAEQ34737718-BD257686-88FD-41EB-B1D3-18A8B8E72417Q34760760-D8EFE1EE-0DF9-4EB2-AB97-F7552C81B357Q34839346-55A87A48-3FC7-4DCC-A54F-A3E66A414974Q35904195-5D9F6603-A90F-4E14-B6C0-BA0A171752C2Q37176647-6B4AACD8-629C-41A4-A2C5-2AA710EEBFF1Q37328307-3B964163-157D-40D6-AC97-98A95F220503Q37335377-41BBD908-008E-4E58-A00E-0D5CBE453BA5Q37389561-B8E76AD4-B979-4D08-A636-A1D423608625Q37516709-780A7A72-1C4A-473D-957A-207B54840BD7Q37612152-B84CBB29-FCB6-434E-98E0-87BFB4CF9078Q37623620-945BB179-0414-4480-B670-357661AFF9BFQ37730006-4DC65A85-16AF-4642-A6C4-E6C0997A716BQ37862752-6916F960-3750-43B1-8B02-5D2D59D7966EQ37889963-6498B453-38F3-4CBA-BF63-DBC0C7DFD512Q38018217-9270FB7B-9744-4ECB-9658-B8B6A1494B87Q38019747-81A721DD-58CA-434D-9A1A-A294289C8E3BQ38118298-C2430C75-3ACD-4078-B972-23F14F5FF9ADQ39533178-A036CE2E-F3D0-48D4-8D75-1EE75DA468FAQ41593380-B5CD4D2E-E872-4755-BF01-92D5E2FCEED6Q41920935-3DBD7ABB-8BD5-4C2A-BF04-A84A2103B251Q43841732-DEEF38BB-567D-47ED-9D88-87EABC4CB064Q48367339-D16BA2B6-8081-4A87-B191-DF7B709BF4B1Q51428846-755B5279-3F70-4AA5-BE4F-D46B3D9A04A9Q52608451-0C1AED5F-027D-4D2A-8EED-8E32DD7A8DD0
P2860
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@ast
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@en
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@nl
type
label
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@ast
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@en
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@nl
prefLabel
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@ast
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@en
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@nl
P2093
P1476
Comparison of osteopontin, meg ...... ts with malignant mesothelioma
@en
P2093
Amanda Segal
Bruce W S Robinson
Deborah Yeoman
Jenette Creaney
Steven J Skates
Yvonne Demelker
P356
10.1097/JTO.0B013E318180477B
P407
P577
2008-08-01T00:00:00Z